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Introduction: The effect of mean arterial pressure titration to a higher level on microcirculation in septic shock
patients with previous hypertension remains unknown. Our goal is to assess the effect of mean arterial pressure
titration to a higher level on microcirculation in hypertensive septic shock patients.
Methods: This is a single-center, open-label study. Hypertensive patients with septic shock for less than 24 hours
after adequate fluid resuscitation and requiring norepinephrine to maintain a mean arterial pressure of 65 mmHg
were enrolled. Mean arterial pressure was then titrated by norepinephrine from 65 mmHg to the normal level of
the patient. In addition to hemodynamic variables, sublingual microcirculation was evaluated by sidestream dark
field imaging.
Results: Nineteen patients were enrolled in the study. Increasing mean arterial pressure from 65 mmHg to normal
levels was associated with increased central venous pressure (from 11 ± 4 to 13 ± 4 mmHg, P = 0.002), cardiac
output (from 5.4 ± 1.4 to 6.4 ± 2.1 l/minute, P = 0.001), and central venous oxygen saturation (from 81 ± 7 to
83 ± 7%, P = 0.001). There were significant increases in small perfused vessel density (from 10.96 ± 2.98 to 11.99 ± 2.55
vessels/mm2, P = 0.009), proportion of small perfused vessels (from 85 ± 18 to 92 ± 14%, P = 0.002), and small
microvascular flow index (from 2.45 ± 0.61 to 2.80 ± 0.68, P = 0.009) when compared with a mean arterial pressure
of 65 mmHg.
Conclusions: Increasing mean arterial pressure from 65 mmHg to normal levels is associated with improved
microcirculation in hypertensive septic shock patients.
Trial registration: Clinicaltrials.gov: NCT01443494; registered 28 September 2011.Introduction
Septic shock is a major cause of death in critically ill
patients and is characterized by hypotension and hypo-
perfusion [1]. Although mortality has been reported to
be decreased due to the progress in therapy for septic
shock [2,3], microcirculation abnormalities can still be
present and contribute to hypoperfusion [4]. Microvascu-
lar dysfunction is associated with organ dysfunction and* Correspondence: haiboq2000@163.com
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crocirculation during resuscitation is associated with re-
duced organ failure [7]. Therefore, therapeutic strategies
aimed at improving the microcirculation are warranted to
mitigate hypoperfusion and organ failure.
Maintaining sufficient perfusion pressure might be an
important way to improve the microcirculatory perfu-
sion [8]. As one of the key determinants of perfusion
pressure, adequate mean arterial pressure (MAP) might
reduce hypoperfusion and organ failure. Correa and col-
leagues [9] have evaluated the effects of different MAP
targets in septic pigs, and show that targeting a MAPis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
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with increased incidence of acute kidney injury when
compared with a target MAP of between 75 and 85 mmHg.
Moreover, Badin and colleagues [10] have reported that
acute kidney injury is decreased with a MAP of at least
72 mmHg. However, which MAP levels should be targeted
to improve microcirculation remains controversial [11-13].
The optimal MAP target in septic shock patients, es-
pecially in patients with previous hypertension, is still
unknown [14]. The guidelines [15] for treating septic
shock have recommended that MAP should be main-
tained at a level of at least 65 mmHg, and emphasized a
higher blood pressure for patients with previous hyper-
tension. A recent published randomized controlled study
[16] has shown no difference in mortality in septic shock
patients undergoing resuscitation with a high MAP target
or a low MAP target. However, among chronic hyperten-
sive patients, those in the high-target group require less
renal replacement therapy, indicating that septic shock pa-
tients with chronic hypertension might need higher MAP
to maintain microcirculation.
Our goal was to assess the effect on the microcircula-
tion of MAP titration to normal levels in septic shock
patients with previous hypertension. We hypothesized
that the increase in MAP from 65 mmHg to the normal




This was a single-center, prospective, open-label study
conducted in the intensive care unit of a tertiary care
teaching hospital. The study protocol was approved by the
Ethics Committee (Approval Number: 2011ZDllKY03.0)
of Zhongda Hospital, School of Medicine, Southeast Uni-
versity, and informed consent was given by each patient
or their next of kin.
Trial registration: Clinicaltrials.gov NCT01443494; reg-
istered 28 November 2011.
Study population
Patients admitted to the intensive care unit who met the
following inclusion criteria were enrolled in the study: 1)
patients with septic shock for less than 24 hours with a
history of previous hypertension (septic shock was de-
fined by the 2001 SCCM/ESICM/ACCP/ATS/SIS Inter-
national Sepsis Definitions Conference [17]); 2) fluid
resuscitation was performed according to the guidelines
for treating septic shock to maintain the central venous
pressure (CVP) at more than 8 mmHg and central venous
oxygen saturation at more than 70%; 3) patients required
norepinephrine (NE) to maintain a MAP of 65 mmHg. All
patients were treated with mechanical ventilation, and
received infusions of morphine and propofol. All patientshad an arterial catheter and a central venous catheter in
place.
Exclusion criteria were: pregnancy; age <18 years;
inability to acquire the usual level of MAP; refusal of
consent by the patient or relative; participation in other
trials during the last 3 months; and hypertensive patients
without antihypertensive therapy.
Interventions
As chronic hypertensive patients are supposed to have
undergone more blood pressure measurements in daily
life than normotensive patients, the average MAP
acquired from a patient’s physical examination records
over the last 2 years was taken to be the target MAP. If
the medical records were incomplete, a detailed enquiry
about the target MAP to their next of kin was perfor-
med. In addition, age, gender, duration of shock prior to
inclusion, Acute Physiology And Chronic Health Evaluation
II score, intensive care unit length of stay, in-hospital
mortality, source of infection and comorbidities were also
recorded.
Study design
After stabilization for 30 minutes, basal measurements
including hemodynamic and microcirculatory measure-
ments were taken 20 minutes apart, and the NE doses
were increased to titrate MAP to the target level. Patients
were allowed to stabilize for 30 minutes before new mea-
surements were taken. Thus, there was 50 minutes be-
tween the baseline and the second measurement. During
the process, no other changes in treatment were allowed.
The decision to stop the research was made by the treat-
ing intensivist according to predetermined safety limits for
each patient. The detailed safety limits are reported in
Additional file 1.
Hemodynamic measurements
Serial measurements of NE dose, MAP, heart rate and
CVP were performed. Noninvasive bioreactance cardiac
output and stroke volume monitoring were obtained
using the NICOM system (Cheetah Medical, Portland,
OR, USA). Arterial and central venous gases were ob-
tained to determine arterial pH, hemoglobin, lactate, arter-
ial partial pressure of oxygen, arterial partial pressure of
carbon dioxide, arterial hemoglobin saturation, arterial
oxygen partial pressure to fractional inspired oxygen ratio
and central venous hemoglobin saturation.
Microcirculatory measurements and analysis
Measurements of the sublingual microcirculation were
obtained using sidestream dark field (SDF; Microscan,
Microvision Medical, Amsterdam, The Netherlands). The
SDF probe was placed under the sublingual area without
pressure after removal of secretions. Video sequences of
Table 1 Baseline patient characteristics
Patient characteristic (n = 19)
Age (years) 74 ± 11
Gender (%) 13 males (68)
Duration of shock prior to inclusion (hours) 16 ± 6
APACHE II score 24 ± 10
Intensive care unit length of stay (days) 12 ± 8
In-hospital mortality (n (%)) 10 (53)
Source of infection (n (%))
Respiratory infection 11 (58)
Abdominal infection 6 (32)
Bacteremia 1 (5)
Urinary tract infection 1 (5)
Comorbidities (n (%))
Chronic hypertension 19 (100)
Diabetes 2 (10)
Chronic renal failure 2 (10)
Usual mean arterial pressure acquired from
previous medical records (mmHg)
93 ± 7
Fluid infusion during the study (ml) 185 ± 55
APACHE, Acute Physiology and Chronic Health Evaluation. Data presented as
mean ± SD or n (%).
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lingual sites. These images were stored and later renum-
bered by an identifier blinded to the clinical course.
Videos were converted to the AVI (audio video inter-
leaved) file format with video processing software, and
analysis for each image was performed by two different in-
vestigators. Finally, all the variables were averaged to yield
a single value for statistical analysis. The microcirculatory
flow index (MFI), based on determination of the pre-
dominant type of flow in four quadrants for small ves-
sels and total vessels, was determined with a semi-
quantitative methodology. Flow was characterized as no
flow = 0, intermittent = 1, sluggish = 2, and continuous = 3,
to reflect blood velocity, identical to that described in
consensus conference recommendations [18]. MFI was
calculated for all quadrants of the image and averaged for
each sublingual site. Detailed methods are reported in
Additional file 2.
Statistical analysis
Statistical analysis of the data was performed using SPSS
16.0 (IBM, Somers, NY, USA). Histograms and normal-
quantile plots were examined and Kolmogorov-Smirnov
test was performed to verify the normality of the distri-
butions of the data. Data are presented as the mean ± SD
if normally distributed or median (interquartile range) if
not normally distributed. Categorical variables are pre-
sented as number and percentage. For continuous data,
paired t test or Wilcoxon signed-rank test were used.
Differences were considered significant at P < 0.05.
Results
Clinical characteristics of study subjects
The main characteristics of the 19 patients are presented
in Table 1. Detailed enquiry about the target MAP to their
next of kin was performed for all of the patients. The aver-
aged value of MAP was 93 mmHg in our study, which
was maintained in the range 80 to 110 mmHg under the
control of medications. The mean duration of shock prior
to study inclusion was 16 hours. In-hospital mortality was
53%. The most common source of sepsis was pneumonia.
Effect on global hemodynamics
Increasing MAP from 65 mmHg to target level (from 71 ±
8 to 91 ± 7 mmHg, P < 0.001) by augmenting NE dose was
associated with significantly increased CVP (from 11 ± 4 to
13 ± 4 mmHg, P = 0.002), cardiac output (from 5.4 ± 1.4
to 6.4 ± 2.1 l/minute, P = 0.001) and central venous oxy-
gen saturation (from 81 ± 7 to 83 ± 7%, P = 0.001) (Table 2,
Figure 1).
Effect on sublingual microcirculation
Although the vascular density and heterogeneity index
were not significantly altered, there were significantincreases in small perfused vessel density (from 10.96 ±
2.98 to 11.99 ± 2.55 vessels/mm2, P = 0.009), propor-
tion of small perfused vessels (from 85 ± 18 to 92 ± 14%,
P = 0.002), and small MFI (from 2.45 ± 0.61 to 2.80 ± 0.68,
P = 0.009) compared with a MAP of 65 mmHg (Table 3).
Meanwhile, little interindividual variability in small per-
fused vessel density (Figures 2 and 3), proportion of small
perfused vessels (Figure 4) or MFI (Figure 5) appeared
(see Additional file 3, a table listing the relationship
between the changes of each microvascular variables and
basal microvascular parameters).
Discussion
The main finding of our study suggested that increasing
MAP to the usual levels in early resuscitated hyperten-
sive septic shock patients was associated with consider-
able microcirculatory improvements, characterized by
increased perfused vessel density, a higher proportion of
small perfused vessels and elevated MFI. Meanwhile, lit-
tle individual variability developed.
Microcirculatory dysfunction plays an important role
in the development of tissue hypoperfusion in patients
with septic shock. Although early goal-directed therapy
is reported to improve their outcome [2], the routine
global hemodynamic parameters such as cardiac output,
central or mixed venous oxygen saturation do not work
as an effective perfusion index in most cases, and organ
failure is still present after rapid correction of global
Table 2 Hemodynamic variables
MAP = 65 mmHg Usual MAP P
Norepinephrine dose (μg/kg/minute) 0.08 (0.04-0.34) 0.25 (0.16-0.68)* <0.001
Systolic arterial pressure (mmHg) 107 ± 19 140 ± 15* <0.001
Diastolic arterial pressure (mmHg) 53 ± 7 66 ± 9* <0.001
Mean arterial pressure (mmHg) 71 ± 8 91 ± 7* <0.001
Heart rate (beats/minute) 100 ± 24 99 ± 21 0.793
Central venous pressure (mmHg) 11 ± 4 13 ± 4* 0.002
Cardiac output (l/minute) 5.4 ± 1.4 6.4 ± 2.1* 0.001
Stroke volume (ml) 57.5 ± 21.2 67.0 ± 26.7* 0.003
Urine output (ml/hour) 56 ± 6 55 ± 6 0.921
Hemoglobin (g/dl) 9.4 ± 1.9 9.5 ± 2.0 0.605
Arterial pH 7.38 ± 0.06 7.39 ± 0.06 0.305
Lactate (mmol/l) 2.3 ± 2.3 2.2 ± 2.3 0.598
Arterial partial pressure of oxygen (mmHg) 132 ± 37 142 ± 51 0.250
Arterial partial pressure of carbon dioxide (mmHg) 30 ± 6 29 ± 6 0.303
Arterial hemoglobin saturation (%) 97.4 ± 1.8 98.0 ± 1.6 0.129
PaO2:FiO2 ratio (mmHg) 259 ± 99 291 ± 104* 0.003
Central venous hemoglobin saturation (%) 81 ± 7 83 ± 7* 0.001
*P < 0.05 versus baseline of mean arterial pressure 65 mmHg. MAP, mean arterial pressure; PaO2:FiO2, arterial oxygen partial pressure to fractional inspired oxygen.
Data presented as means ± SD or median (interquartile range).
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responsible for regulating tissue perfusion to meet oxygen
requirements and is associated with the development of
organ dysfunction. Therefore, it is important to monitor
and manage the microcirculation in order to augment
perfusion in patients with septic shock.
An adequate MAP is typically essential to restore
effective perfusion pressure and organ perfusion in sep-
tic shock patients. As the most common pre-existingFigure 1 Baseline and target mean arterial pressure as well as baseline
pressure. NE, norepinephrine.condition in patients with septic shock [16], the Surviv-
ing Sepsis Campaign guidelines [15] have recommended
a higher, but vague, blood pressure for patients with pre-
vious hypertension. Moreover, MAP targets in clinical
trials varies substantially, ranging from 60 to 110 mmHg
[19]. Few trials have focused on the effect of different
MAP targets in septic shock patients with previous
hypertension, let alone which MAP levels should be tar-
geted to improve microcirculation.and final norepinephrine doses are displayed. MAP, mean arterial
Table 3 Sidestream dark field variables
MAP = 65 mmHg Usual MAP P
Small vessel density (vessels/mm2) 11.29 ± 2.18 11.91 ± 2.14 0.129
Total vessel density (vessels/mm2) 12.35 ± 2.29 12.76 ± 2.09 0.227
Small perfused vessel density (vessels/mm2) 10.96 ± 2.98 11.99 ± 2.55* 0.009
Total perfused vessel density (vessels/mm2) 11.34 ± 3.03 12.24 ± 2.55* 0.021
Proportion of small perfused vessels (%) 85 ± 18 92 ± 14* 0.002
Proportion of total perfused vessels (%) 92 ± 18 96 ± 12* 0.029
Small microvascular flow index 2.45 ± 0.61 2.80 ± 0.68* 0.009
Total microvascular flow index 2.70 ± 0.52 3.05 ± 0.51* 0.002
Heterogeneity index of small diameter vessels 0.59 ± 0.32 0.47 ± 0.27 0.145
Heterogeneity index of total diameter vessels 0.36 ± 0.27 0.30 ± 0.19 0.330
*P < 0.05 versus baseline of mean arterial pressure 65 mmHg. MAP, mean arterial pressure. Data presented as means ± SD.
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pressure-flow autoregulation [20], which suggests a higher
MAP should be targeted in patients with these conditions
to maintain organ perfusion. Moreover, a recently pub-
lished study [16] has observed less renal replacement ther-
apy in the high-target group in septic shock patients with
previous hypertension, suggesting that higher MAP might
reduce hypoperfusion and organ failure in these patients.
However, few studies have looked at the microvascular re-
sponses to higher MAP titration in septic shock patients
with previous hypertension.
In our study, increasing MAP from 65 mmHg to
the usual levels of the patients resulted in improvedFigure 2 Results of small perfused vessel density are shown as
the mean arterial pressure increased from 65 mmHg to usual
level with norepinephrine. MAP, mean arterial pressure.microcirculatory function in these septic shock patients
with previous hypertension, although the cause and effect
are unclear. NE was used to titrate MAP to the usual level.
As the key vasoactive agent recommended for restoring
MAP in the treatment of septic shock, NE might not only
perform as the vasopressor but also affect preload and
tissue perfusion. Increasing the dose of NE significantly
augments cardiac output by 11 to 17% [21], suggesting NE
might recruit some blood from the large venous un-
stressed volume as another method of “endogenous fluid
challenge”. Since fluid challenge is demonstrated to im-
prove microvascular perfusion in the early phase of septic
shock [22,23], NE-induced microcirculatory improvement
might occur because of its role on arterial pressure preser-
vation and blood recruitment.
An NE-induced cardiac output effect might be another
reason for the improvement in the microcirculation:
rapidly achieving a sufficient perfusion pressure could
increase cardiac output in septic shock patients [24].
Georger and colleagues [25] found that NE administra-
tion is associated with an increase in MAP and cardiac
index, which resulted in improvements of near-infrared
spectroscopy variables in septic shock patients. In our
study, the NE-induced increase in cardiac output was
1 l/minute on average, which might be another reason
for the microcirculatory improvement.
In our study, fluid resuscitation was performed accord-
ing to the guidelines to maintain a CVP of more than
8 mmHg and central venous oxygen saturation of more
than 70% before patients were enrolled, and the basal
measurements were taken after a MAP of 65 mmHg was
achieved by fluids and NE. This differs from other studies
where baseline measurements were taken in the unresus-
citated septic shock patients. As a result, the sublingual
microcirculation at baseline in our study seems to be less
altered when compared with other studies. However, they
were similar to microcirculatory parameters in resusci-
tated septic shock patients [11,12,22].
Figure 3 Relationship between the changes in small perfused vessel density, when mean arterial pressure increased from 65 mmHg to
usual levels, with the basal small perfused vessel density at a mean arterial pressure of 65 mmHg.
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are reported in septic shock patients after MAP titration
despite fluid resuscitation [12,26], which indicates that
the level of MAP should be adapted in consideration of
the interindividual effect. In this study, titration to a
pressure closer to that of a given patient’s baseline
aimed to reduce the interindividual variability, and re-
veals the microcirculatory alterations after MAP titration
to a higher level in septic shock patients with previous
hypertension.Figure 4 Results of proportion of small perfused vessels are
shown as the mean arterial pressure increased from 65 mmHg
to usual levels with norepinephrine. MAP, mean arterial pressure.Limitations
Our study has some limitations. Firstly, cardiac output
was monitored by the NICOM system to minimize
operative invasion. Although the most widely trusted
technology for measuring cardiac output is still bolus
thermodilution, NICOM is found to have similar moni-
toring capabilities compared with bolus thermodilution
[27,28]. Secondly, the target MAP level was obtained
from previous physical examination records or was given
by relatives. Although patients with chronic hyperten-
sion often undergo more blood pressure measurementsFigure 5 Results of microvascular flow index are shown as the
mean arterial pressure increased from 65 mmHg to usual levels
with norepinephrine. MAP, mean arterial pressure.
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be over- or underestimated. Moreover, higher doses of NE
may be associated with arrhythmias and other adverse
events, which were not observed in our study. Last, but
not the least, no assessment of fluid responsiveness was
undertaken in our study. NE might have different effects
on the microcirculation in patients with or without fluid
responsiveness.
It is also important to note that this study is not a con-
trolled study, and lacks a control group and a return to
baseline blood pressure. Each patient, therefore, served
as his/her own control when increasing MAP from
65 mmHg to the usual level. In addition, the lack of
normotensive controls makes the results difficult to ex-
tend to normotensive subjects. However, there are sev-
eral studies [11,12] focusing on the role of different
MAP targets in normotensive patients with septic shock.
In a large multicenter, open-label trial [16], targeting a
MAP of 80 to 85 mmHg, as compared with 65 to
70 mmHg, resulted in no significant differences in mortality
for septic shock patients.Conclusions
In this open-label intervention study, increasing MAP
from 65 mmHg to the usual level in patients was associ-
ated with improved microcirculatory function in septic
shock patients with previous hypertension.Key messages
 Increasing MAP from 65 mmHg to the usual level
in patients by NE was associated with increased
CVP, cardiac output and central venous oxygen
saturation in hypertensive septic shock patients.
 Increasing MAP from 65 mmHg to the usual level
in patients by NE was associated with increased
small perfused vessel density, proportion of small
perfused vessels, and small microvascular flow index
in hypertensive septic shock patients.Additional files
Additional file 1: Study design: predetermined safety limits.
Additional file 2: Microcirculatory measurements and analysis:
detailed microcirculatory measurements and analysis.
Additional file 3: Results: relationship between the changes of each
microvascular variable and basal microvascular parameters.
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